Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 4,912 |
|
|||||
| News | - | ||||||
| Day High | 105.81 | Low High |
|||||
| Day Low | 105.1008 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Blueprint Medicines Corporation | BPMC | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -1.61 | -1.51% | 105.1008 | 08:37:39 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 105.81 | 105.1008 | 105.81 | 106.71 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 65 | 4,912 | US$ 105.76 | US$ 519,475 | - | 43.89 - 111.02 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 08:37:39 | 1 | US$ 104.6569 | USD |
Blueprint Medicines Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 6.53B | 61.23M | - | 249.38M | -506.98M | -8.28 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Blueprint Medicines News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BPMC Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 106.14 | 108.115 | 102.55 | 105.38 | 526,031 | -1.04 | -0.98% |
| 1 Month | 103.49 | 109.37 | 99.16 | 104.43 | 527,931 | 1.61 | 1.56% |
| 3 Months | 95.00 | 111.02 | 84.33 | 99.26 | 602,041 | 10.10 | 10.63% |
| 6 Months | 88.01 | 111.02 | 72.24 | 91.57 | 717,728 | 17.09 | 19.42% |
| 1 Year | 61.31 | 111.02 | 43.89 | 75.64 | 719,253 | 43.79 | 71.43% |
| 3 Years | 82.59 | 117.86 | 37.82 | 68.47 | 655,180 | 22.51 | 27.26% |
| 5 Years | 98.00 | 125.61 | 37.82 | 72.68 | 603,088 | 7.10 | 7.25% |
Blueprint Medicines Description
| Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates BLU-285, which targets KIT Exon 17 mutants and PDGFRa D842V, abnormally active receptor tyrosine kinase mutants that are drivers of cancer and proliferative disorders. Its other drug candidate is BLU 554 FOR Advanced Hepatocellular Carcinoma, and BLU-667 for Ret Mutations, Fusions, and Predicted Resistant Mutants. |
